The neoadjuvant immunotherapy for non-metastatic mismatch repair-deficient colorectal cancer: a systematic review

The neoadjuvant immunotherapy for non-metastatic mismatch repair-deficient colorectal cancer: a systematic review

BackgroundImmunotherapy has become the first-line treatment for metastatic mismatch repair deficient (dMMR) colorectal cancer. The efficacy and safety of neoadjuvant immunotherapy for the treatment of non-metastatic dMMR colorectal cancer remain unclear. In this article, we explore the clinical effe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hong-Xia Cui, Xiao-Quan Yang, Guang-yue Zhao, Feng-jian Wang, Xin Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Immunology
Subjects:	neoadjuvant immunotherapy non-metastatic colorectal cancer mismatch repair-deficient pCR meta-analysis.
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1540751/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency
by: Wu Yunlong, et al.
Published: (2023-02-01)

Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 studyResearch in context
by: Liying Zhao, et al.
Published: (2025-09-01)

Updates on DNA Repair Gene Deficiency in Colorectal Cancer (dMMR)
by: Gustavo Sevá-Pereira, et al.
Published: (2025-03-01)

This is not Lynch syndrome: lessons from misattributed diagnoses in constitutional mismatch repair deficiency
by: A.H. Mohammad, et al.
Published: (2024-12-01)

Immunotherapy strategies and pharmaceutical care practice on a long-term surviving patient with advanced gastric cancer and mismatch repair deficient
by: Jinyin LI, et al.
Published: (2025-08-01)

Risk factors and a predictive nomogram for regional lymph node metastasis in deficient mismatch repair colorectal cancer
by: Jiawei He, et al.
Published: (2025-06-01)

Reassessing the Prognostic Value of Lymph Node Metastasis in Deficient Mismatch Repair Colorectal Cancer
by: Zilan Ye, et al.
Published: (2025-04-01)

Case Report: Metastatic small bowel adenocarcinoma with DNA mismatch repair deficiency in an organ transplant recipient treated with anti-PD-1 immunotherapy
by: Quan H. Phung, et al.
Published: (2025-06-01)

Case Report: A long-term response of immunotherapy combined with anti-angiogenesis therapy in a patient with dMMR metastatic colorectal cancer after ICI failure
by: Qianwen Huang, et al.
Published: (2025-04-01)

Utility of pembrolizumab for metastatic castrate resistant prostate cancer with MMR deficiency
by: Brian F. Dinerman, et al.
Published: (2024-11-01)

Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization
by: Daniela A. Ferraro, et al.
Published: (2025-04-01)

Clinical Molecular Immunohistochemistry Mismatch Repair Mutations in Lynch Syndrome in Patients Under 50 Years: A Systematic Review
by: Bogdan Adrian Manta, et al.
Published: (2025-04-01)

Cerebral developmental venous anomalies in children with mismatch repair deficiency
by: Buket Kara, et al.
Published: (2022-12-01)

Spontaneous regression of advanced transverse colon cancer with deficient mismatch repair: a case report
by: Shinnosuke Harata, et al.
Published: (2023-04-01)

Advances and future perspectives of neoadjuvant immunotherapy in colorectal cancer
by: ZHANG Yuyang, LIU Qian
Published: (2025-07-01)

Programmed death‐ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2‐negative status
by: Lei Wang, et al.
Published: (2018-06-01)

Factors influencing pathological complete response following neoadjuvant chemoimmunotherapy in locally advanced microsatellite stable colorectal cancer: a retrospective analysis
by: Mingxiang Liu, et al.
Published: (2025-06-01)

Clinical Implications of Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma
by: Zachary Kaplan, et al.
Published: (2025-05-01)

Triplet Regimen of Metronomic Capecitabine Plus Antiangiogenic Drug and PD‐1 Inhibitor as Later‐Line Salvage Treatment for Patients With MSS/pMMR Metastatic Colorectal Cancer: A Retrospective Study
by: Qiong Yang, et al.
Published: (2025-07-01)

Durable Clinical Benefit after Dual Checkpoint Inhibition and Single-agent Nivolumab Following Pembrolizumab Failure in Mismatch Repair-deficient Colon Cancer
by: Yat-Fung Chow, et al.
Published: (2023-10-01)

Early-onset colorectal cancer: a retrospective study of demographic, clinicopathological, and molecular characteristics in a single Chinese center
by: Zongyao Chen, et al.
Published: (2025-08-01)

Lynch Syndrome—Impact of the Type of Deficient Mismatch Repair Gene Mutation on Diagnosis, Clinical Presentation, Surveillance and Therapeutic Approaches
by: Tudor Razvan Grigorie, et al.
Published: (2025-01-01)

The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression
by: Kirsten Brooksbank, et al.
Published: (2025-09-01)

The trends and hotspots of immunotherapy for metastatic colorectal cancer from 2013 to 2022: A bibliometric and visual analysis
by: Yifan Gong, et al.
Published: (2024-12-01)

A PET-CT radiomics model for immunotherapy response and prognosis prediction in patients with metastatic colorectal cancer
by: Wenbiao Chen, et al.
Published: (2025-05-01)

Negative response to immunotherapy in dMMR or MSI-H gastric cancer with APC and PTEN mutations: a case report
by: Jiang Liu, et al.
Published: (2024-11-01)

Microsatellite instability in stage II and III colorectal cancer: Patterns and profile
by: A P Dubey, et al.
Published: (2018-01-01)

The efficacy and safety of neoadjuvant and adjuvant chemo(radio)therapy combined with surgery in patients with locally advanced rectal cancer harboring defective mismatch repair system: a large-scale multicenter propensity score analysis
by: Huan-Huan Wang, et al.
Published: (2025-07-01)

Insights into immune-related adverse events in colorectal cancer patients receiving neoadjuvant immunotherapy: findings from a multicenter registry study
by: Chentong Wang, et al.
Published: (2025-06-01)

Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor
by: Koushiro Ohtsubo, et al.
Published: (2025-03-01)

Research progress of immune checkpoint inhibitors in neoadjuvant immunotherapy for dMMR/MSI-H locally advanced colorectal cancer
by: Zhu Xi, et al.
Published: (2024-02-01)

Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
by: Yupeng Jiang, et al.
Published: (2025-02-01)

Assessing pathogenicity of mismatch repair variants of uncertain significance by molecular tumor analysis
by: Anne-Sophie van der Werf't Lam, et al.
Published: (2024-12-01)

Postoperative adjuvant chemotherapy in patients with stage II early onset colorectal cancer: exploration and discovery using real-world data and the SEER database
by: Shikun Cao, et al.
Published: (2025-05-01)

Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis
by: Yiran Zhang, et al.
Published: (2025-06-01)

Joint inference of mutational signatures from indels and single-nucleotide substitutions reveals prognostic impact of DNA repair deficiencies
by: Patricia Ferrer-Torres, et al.
Published: (2025-07-01)

Updated long-term survival outcomes for patients with locally advanced gastric cancer having pathological complete response after neoadjuvant therapy at China National Cancer Center, 2004–2023
by: Chongyuan Sun, et al.
Published: (2025-06-01)

Rectal stenosis after immunotherapy in a mismatch repair deficient rectal cancer. Case report and review of literature
by: Marcel Büttner, et al.
Published: (2025-07-01)

Treatment sequencing in metastatic colorectal cancer
by: Nanteznta Torounidou, et al.
Published: (2025-01-01)

The prognosis prediction value of CD69+ CD8+ tissue-resident memory T cell as a novel indicator of pathologic complete response heterogeneity following different neoadjuvant therapy regimen in esophageal squamous cell carcinoma
by: Ao Liu, et al.
Published: (2025-03-01)